For the cumulative third quarter of the fiscal year ending March 2026, net sales were 598.3 billion yen (YoY -0.8%), operating income was 22.2 billion yen (YoY -23.8%), and quarterly net income was 18.4 billion yen (YoY +4.0%).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4118","jir_company_name":"Kaneka Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-02-10","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/02\/4118-20260210-02.pdf","jir_short_summary":"For the cumulative third quarter of the fiscal year ending March 2026, net sales were 598.3 billion yen (YoY -0.8%), operating income was 22.2 billion yen (YoY -23.8%), and quarterly net income was 18.4 billion yen (YoY +4.0%).","jir_summary":"### Overview of Financial Results\nNet sales for the cumulative third quarter of the fiscal year ending March 2026 were 598.3 billion yen, down 0.8% year-over-year. Operating income was 22.2 billion yen, a 23.8% decrease year-over-year, while quarterly net income increased by 4.0% to 18.4 billion yen. The decline in operating income was mainly due to sluggish performance in the Asian vinyls market and prolonged weakness in U.S. housing and construction demand. Conversely, the Medical business expansion drove the earnings. Gains on sales of policy-held shares amounting to 10.2 billion yen contributed to the increase in net income.\n\n### Segment Performance and Future Outlook\nBy segment, Material SU recorded net sales of 241.5 billion yen (YoY -5.5%) and operating income of 17.8 billion yen (YoY -21.8%), posting decreases in both sales and profits. Quality of Life SU posted net sales of 145.4 billion yen (YoY +0.8%) and operating income of 14.3 billion yen (YoY -9.2%), remaining roughly flat. Health Care SU achieved net sales of 57.3 billion yen (YoY +3.4%) and operating income of 9.6 billion yen (YoY +9.7%), marking sales and profit growth. Nutrition SU saw increased sales but decreased profits. The consolidated earnings forecast has been revised downward from the previous forecast, with net sales of 800.0 billion yen, operating income of 34.0 billion yen, and net income of 31.5 billion yen, although progress is being made in strengthening life sciences and social implementation of new products in key areas.","jir_financial_highlights":"Net Sales: 598.3 billion yen (YoY -0.8%)\nOperating Income: 22.2 billion yen (YoY -23.8%)\nNet Income Attributable to Owners of Parent: 18.4 billion yen (YoY +4.0%)","jir_category":"","jir_hashtags":"#Kaneka, #FinancialPresentation, #JapaneseStocks","jir_key_figures":"Net Sales: 598.3 billion yen (YoY -0.8%)\nOperating Income: 22.2 billion yen (YoY -23.8%)\nQuarterly Net Income: 18.4 billion yen (YoY +4.0%)","jir_meta_title":"Kaneka FY2026 Q3 Financial Results: Net Sales 598.3 Billion Yen, Operating Income 22.2 Billion Yen","jir_meta_description":"Kaneka's FY2026 Q3 financial results show net sales of 598.3 billion yen (YoY -0.8%), operating income of 22.2 billion yen (YoY -23.8%), and quarterly net income of 18.4 billion yen (YoY +4.0%). Medical business expansion drives earnings growth.","jir_og_title":"Kaneka FY2026 Q3 Financial Results Announcement: Sales and Profit Trends","jir_og_description":"Kaneka's FY2026 Q3 financial results: net sales 598.3 billion yen, operating income 22.2 billion yen, net income 18.4 billion yen. Strong performance in the Medical business contributed to net income growth.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Net Sales Trend (Cumulative 3Q)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Fiscal Year Ending March 2025\\\",\\\"Fiscal Year Ending March 2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales (billion yen)\\\",\\\"data\\\":[6030,5983],\\\"backgroundColor\\\":\\\"#005BAC\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Operating Income Trend (Cumulative 3Q)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Fiscal Year Ending March 2025\\\",\\\"Fiscal Year Ending March 2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income (billion yen)\\\",\\\"data\\\":[291,222],\\\"backgroundColor\\\":\\\"#007ACC\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Net Sales Breakdown (Cumulative 3Q)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Material SU\\\",\\\"Quality of Life SU\\\",\\\"Health Care SU\\\",\\\"Nutrition SU\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Fiscal Year Ending March 2025 (billion yen)\\\",\\\"data\\\":[2555,1443,554,1471],\\\"backgroundColor\\\":\\\"#B0C4DE\\\"},{\\\"label\\\":\\\"Fiscal Year Ending March 2026 (billion yen)\\\",\\\"data\\\":[2415,1454,573,1533],\\\"backgroundColor\\\":\\\"#005BAC\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"segment_operating_profit_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Operating Income Breakdown (Cumulative 3Q)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Material SU\\\",\\\"Quality of Life SU\\\",\\\"Health Care SU\\\",\\\"Nutrition SU\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Fiscal Year Ending March 2025 (billion yen)\\\",\\\"data\\\":[227,157,87,101],\\\"backgroundColor\\\":\\\"#B0C4DE\\\"},{\\\"label\\\":\\\"Fiscal Year Ending March 2026 (billion yen)\\\",\\\"data\\\":[178,143,96,95],\\\"backgroundColor\\\":\\\"#007ACC\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"forecast_comparison\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Comparison of Consolidated Earnings Forecast (Net Sales, Operating Income, Net Income)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Net Sales\\\",\\\"Operating Income\\\",\\\"Net Income Attributable to Owners of Parent\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Fiscal Year Ending March 2025 Actual (billion yen)\\\",\\\"data\\\":[8072,401,253],\\\"backgroundColor\\\":\\\"#B0C4DE\\\"},{\\\"label\\\":\\\"Previous FY2026 Forecast (billion yen)\\\",\\\"data\\\":[8000,370,330],\\\"backgroundColor\\\":\\\"#005BAC\\\"},{\\\"label\\\":\\\"Revised FY2026 Forecast (billion yen)\\\",\\\"data\\\":[8000,340,315],\\\"backgroundColor\\\":\\\"#003366\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}]","ir_related_company":8200,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-27316","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n